Beta Drugs Share Price
₹1,905.00 +15.2 (0.8%)
21 Jan, 2025 04:57
Start SIP in BETA
Start SIPPerformance
- Low
- ₹1,850
- High
- ₹1,920
- 52 Week Low
- ₹1,060
- 52 Week High
- ₹2,326
- Open Price₹1,890
- Previous Close₹1,890
- Volume2,900
Investment Returns
- Over 1 Month -10.44%
- Over 3 Month + 0.68%
- Over 6 Month + 46.48%
- Over 1 Year + 33%
Smart Investing Starts Here Start SIP with Beta Drugs for Steady Growth!
Beta Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 50.3
- PEG Ratio
- -
- Market Cap Cr
- 1,831
- P/B Ratio
- 10.1
- Average True Range
- 90.73
- EPS
- 37.9
- Dividend Yield
- 0
- MACD Signal
- -42.36
- RSI
- 43.72
- MFI
- 34.08
Beta Drugs Financials
Beta Drugs Technicals
EMA & SMA
Current Price
₹1,905.00
+
15.2
(0.8%)
- Bearish Moving Average 10
- Bullish Moving Average 6
- 20 Day
- ₹1,969.26
- 50 Day
- ₹1,990.11
- 100 Day
- ₹1,887.70
- 200 Day
- ₹1,689.83
Resistance and Support
1891.67
- R3 2,003.33
- R2 1,961.67
- R1 1,933.33
- S1 1,863.33
- S2 1,821.67
- S3 1,793.33
Beta Drugs Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-06 | Quarterly Results | |
2024-10-19 | To consider Fund Raising | |
2024-05-14 | Audited Results | |
2023-11-07 | Quarterly Results & Others | To consider the Migration of the Equity shares of the Company from Emerge-SME Platform of National Stock Exchange of India Limited ( NSE Emerge ) to the Main board of NSE and BSE. |
2023-05-08 | Audited Results |
Beta Drugs F&O
About Beta Drugs
- NSE Symbol
- BETA
- BSE Symbol
- 531481
- Chairperson & Managing Director
- Mr. Rahul Batra
- ISIN
- INE351Y01019
Similar Stocks to Beta Drugs
Beta Drugs FAQs
Beta Drugs share price is ₹1,905 As on 21 January, 2025 | 04:43
The Market Cap of Beta Drugs is ₹1831.4 Cr As on 21 January, 2025 | 04:43
The P/E ratio of Beta Drugs is 50.3 As on 21 January, 2025 | 04:43
The PB ratio of Beta Drugs is 10.1 As on 21 January, 2025 | 04:43
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.